Aristotle University Of Thessaloniki (AUTH)
Η επίδραση της δικλοφενάκης και σιμβαστατίνης στην επούλωση οστικών ελλειμμάτων: πειραματική μελέτη
Abstract
dc:descriptionNSAlDs and statins are two widely prescribed drug classes that differentially affect bone healing and bone formation, positively or negatively. Scientific data on this subject remains inconclusive, hence the aim of this study is to elucidate the effect of diclofenac and simvastatin in artificial bone defect healing. Among the NSAIDs diclofenac was chosen (Voltaren®: Novartis Hellas), which was intramuscularly administered in a dose of 5 mg/kg BW/day for a given period of time. Among statins simvastatin was studied (Sigma-Aldrich, USA), which was administered systematically and locally. Simvastatin was dissolved in water for injection (WFI) or in 50% v/v DMSO in WFI and intraperitoneal^ administered in a dose of 10 mg/kg BW daily for a given period of study. Local administration included a solution of simvastatin dissolved in WFI or in a DMSO solution and administered in a dose of 0 5 mg in each defect. 144 male Wistar rats weighing -350 g were employed. Two parietal bone defects were formed in each rat, hence a total of 288 bone defects were studied, out of which 195 were ultimately used for histological evaluation. Specimens were divided into 7 main groups with respect to i) the route of administration of the pharmacological agents under study and ii) the method of defect healing (with or without collagen membrane) and 18 subgroups with respect to the study duration that was either 2, 4 or 8 weeks. The following experimental methods were used: Using a trephine bar of an outer diameter of 6 mm and using saline to prevent excess heating, a bone defect of a diameter of 6 mm was formed on each parietal bone, next to the sagital midline. Depending on the group the procedure was followed by i) surgical wound suturing without any further treatment (group A as well as all the systematic administration groups) or ii) placing of a water for injection-conditioned collagen sponge membrane into the defects and wound suturing. In the respective groups and in order to examine the local effect of simvastatin, 0.1 ml of a solution of simvastatin 5 mg/ml in water for injection or in DMSO were applied on the membrane. Animals were sacrificed after 2, 4 or 8 weeks with respect to the protocol and the group and the specimens were appropriately for histo-morphometric study. Results (per subgroup) include: number of specimens (n), percentage % of new bone formation per specimen and mean and standard deviation of the percentage of new bone formation per group. Statistical analysis was performed with SPSS Software and Mann-Witney-U test for independent samples. In detail, statistical analysis referred to the comparison of the percentage % of bone healing with respect to study duration between: • Subgroups within each group, in order to assess the difference in percentage of bone healing between different study durations. • Subgroups of different groups (with respect to route of administration), in order to assess differences in bone healing percentage between specimens that came from groups of the same study duration. • Subgroups within different groups with the same route of administration and approximately. Comparative analysis of results demonstrated the following: 1. Normal large bone defect healing without any intervention (group A) develops more stably and periodically than all other groups, with statistically significant bone density increase between 2nd and 8th post-operative week. 2. The results of the group of bone healing with the use of a collagen membrane (Group B) indicate some positive effects of the membrane at 2 weeks post-operatively, that become significant at 4 weeks post-operatively, i.e. at the time when the membranes has been already absorbed 3. Diclofenac (DFS group) exerts a direct inhibitory effect on bone healing when systematically administered, in agreement with recent evidence that it exerts this role through decrease in BMP-7 also known as osteopontin 1 (OP-1), that is necessary for bone formation. 4. Intraperitoneal simvastatin injection (10 mg/kg BW daily, group STS), although initially led to the statistically significant increase in bone healing up to the 2nd week, provoked a statistically significant decrease in bone formation (STS1 vs STS2). This finding suggests a positive, followed by a negative effect of simvastatin on osteogenesis when administered systematically. This action is likely not direct but a secondary effect of severe myopathy that was observed in by means of histology. 5. Simvastatin, the most widely used statin, appears to have the ability to promote bone healing even in large bone defects and this is apparent when administered systematically and more precisely, in this study, intraperitoneal. 6. This promoting effect is ameliorated with the administration in a DMSO solution (STDS group), a solvent that seems to have the ability to promote the more efficient delivery and absorption of simvastatin, locally as well as systematically. 7. Besides, toxic effects of systematically administered simvastatin were observed, mainly myopathy that induced a severe fatigue to the animal. Myopathy was a main limiting factor for the survival of the animals after the 5th post-operative week and for the bone healing process. The latter can be postulated given that the initially promoting effect of simvastatin, observed by comparison of groups of study at 2 weeks post-operatively, later ceases to be observed for simvastatin administered in water for injection and in DMSO. 8. The explanation of the effects of simvastatin on bone healing seem to implicate the concept of its pleiotropic actions, i.e. the inhibition of mevalonic acid and activation of BMP-2, a major bone formation-promoting protein. 9. Local administration of 0.5 mg of simvastatin has a rather inhibitory effect on large bone defect healing but this seems to "turn for the best" when administered in a DMSO solution, an element to further clarify regarding dose and time of application, as well as the composition of the solution. 10. An impressive finding of this study is the observation of the process of bone defect healing between groups A (normal healing without intervention) and Β (collagen membrane application). Normal healing appeared more efficient with a stable increase in bone density in all time-points and significantly increased compared to this of group Β rats in 2 weeks post-operatively. The process of bone defect healing in these two groups seems to converge with no more observation of significant differences in bone density after 4 and 8 weeks post-operatively, i.e. when membrane has already started being absorbed.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Georgopoulou-Karanikola, Theodora
- Γεωργοπούλου-Καρανικόλα, Θεοδώρα
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29145